Biotron Limited
A$0.00A$0.00 (0.0%)
Biotron Limited’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
OTC · DYNTQ · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Dynatronics Corporation’s quoted price sits in the lower half of its reported 52-week range, 99.83% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Dynatronics Corporation’s next earnings report is currently expected on Nov 12, 2026, with estimated earnings per share of -$0.38. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Dynatronics Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Dynatronics Corporation operates as a medical device enterprise, specializing in the development, manufacturing, and distribution of a wide array of products geared towards physical therapy, rehabilitation, orthopedics, pain management, and athletic training, primarily within the United States. Their extensive portfolio of orthopedic soft bracing solutions includes items like cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity support garments, knee immobilizers and stabilizers, ankle walkers and braces, plantar fasciitis splints, and cold therapy products. The company also furnishes therapeutic modality devices, such as electrotherapy units, ultrasound equipment, phototherapy systems, medical lasers, shortwave diathermy machines, radial pulse therapy tools, hot and cold treatment options, compression therapy systems, and various electrodes. Moreover, Dynatronics provides a range of rehabilitation and exercise apparatus, encompassing both powered and manually operated treatment tables, mat platforms, specialized work tables, parallel bars, training stairs, weight racks, treadmills, and other related physical therapy equipment. To round out its offerings, the firm supplies clinical consumables like exercise bands and tubing, topical lotions and gels, supplementary orthopedic bracing products, paper goods, and other essential clinic provisions. Dynatronics markets its products under recognized brands, including Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM. Its customer base is diverse, reaching orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. Additionally, products are sold directly to consumers online. The company extends its reach internationally, exporting its goods to approximately 30 countries. Founded in 1979, Dynatronics Corporation is headquartered in Eagan, Minnesota.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:12 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q4 2024 | Sep 24, 2024 | -$0.43-65.38% vs estimate | $7.38M-17.12% vs estimate |
|---|
| Q3 2024 | May 9, 2024 | -$0.17+34.62% vs estimate | $7.66M-12.78% vs estimate |
|---|
| Q2 2024 | Feb 8, 2024 | -$0.27-8.0% vs estimate | $8.15M+1.89% vs estimate |
|---|
THE ANALYST VIEW
4 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$0.00A$0.00 (0.0%)
Biotron Limited’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
$0.00-$0.00 (-11.11%)
Premier Graphene, Inc.’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
$0.00$0.00 (0.0%)
Global Roundtable Corporation’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Itonis, Inc.’s quoted price sits in the lower half of its reported 52-week range, 33.33% below the high.
$0.02$0.00 (0.0%)
Mednow Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01$0.00 (0.0%)
Verisante Technology Inc.’s quoted price sits in the upper half of its reported 52-week range, 23.08% below the high.
$0.02$0.00 (0.0%)
EGF Theramed Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 87.43% below the high.
$0.02$0.00 (0.0%)
Imaging Dynamics Company Ltd.’s quoted price sits in the lower half of its reported 52-week range, 21.67% below the high.